Bayan Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: openly published flat monthly pricing with microdose tiers below standard
Price is where Bayan Health scores best in our breakdown.
What the monthly price covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Bayan Health (bayantelehealth.com) is a physician-led GLP-1 telehealth brand selling compounded semaglutide and tirzepatide as once-weekly injections paired with vitamin B6, plus needle-free oral drop versions of both. Pricing is published openly on a WooCommerce storefront as a flat monthly subscription per protocol, with microdose tiers priced below the standard ones. Purchases are marked HSA/FSA eligible.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Bayan Health
Editorial score · methodology
Try Ageless
Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms
Editorial score · methodology
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Bayan Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99/mo (Microdose tier, sold with vitamin B6. Billed as a monthly subscription.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- FDA status
- No FDA warning letter on record
How we scored Bayan Health
Each dimension is scored algorithmically from Bayan Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.9/10At $99/mo, Bayan Health runs about 41% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Bayan Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.5/10Online intake and platform experience; 2 platform features disclosed.
Trust & Safety15%
6.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-17).
Accessibility10%
5.7/10Bayan Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Bayan Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Bayan Health review
Last checked August 2026- Confirmed current pricing across 6 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Bayan Health
We walked Bayan Health’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the weight-loss protocol storefront, where every purchasable product shows a flat monthly price before any account or intake.
- 2Choose a protocol (microdose or standard, injection or oral drops) and select Get Started on that product.
- 3Complete the checkout and intake flow for a monthly subscription product; a licensed physician reviews before anything is prescribed.
- All six purchasable prices are visible on the category page with no account, no email and no intake: $99 and $119 microdose, $129 and $149 standard, $99 and $119 oral drops.
- Four further products are displayed as Coming soon with no price at all, including retatrutide and orforglipron, so the catalog advertises more than it sells.
- Products are sold as monthly subscriptions rather than one-off orders (WooCommerce product-type-subscription).
- Purchases are marked HSA/FSA eligible, with eligibility stated to vary by individual plan.
- Site copy promises transparent pricing, no hidden fees, and prices are indeed published, which is unusual in this segment.
- Walk stopped at checkout: no account created, no personal or health data entered.
GLP-1 medications Bayan Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Microdose tier, sold with vitamin B6. Billed as a monthly subscription.
Microdose tier, sold with vitamin B6. Billed as a monthly subscription.
Sold with vitamin B6. Billed as a monthly subscription.
Sold with vitamin B6. Billed as a monthly subscription.
Oral drop formulation. No published pharmacokinetic data for this route.
Oral drop formulation. No published pharmacokinetic data for this route.
Ready to get started?
Plans and promotions change often — check Bayan Health's current pricing and active discounts before you decide.
What we like
- Prices published openly on the storefront — every protocol shows a flat monthly figure with no gate
- Microdose tiers priced below the standard tiers, which is uncommon and useful for low-dose starters
- Purchases marked HSA/FSA eligible
- Both semaglutide and tirzepatide offered, so switching molecules does not mean switching providers
Watch-outs
- Oral drop formulations are sold without any published pharmacokinetic evidence for that route
- States served are not enumerated anywhere on the site
- No LegitScript badge displayed and no dispensing pharmacy named
- Four products are advertised as coming soon, including retatrutide, which is not FDA-approved for anything
Is Bayan Health worth it? Our verdict
Bayan Health positions itself around one thing: openly published flat monthly pricing with microdose tiers below standard. It runs $99/month, flat across every dose — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
On top of the prescription itself, Bayan Health points to Brand Name.
How much Bayan Health actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $119/month
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $149/month
- Oral semaglutide — $99/month
- Oral tirzepatide — $119/month
That puts Bayan Health below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
bmiMD (about $99/month) is one of the closest alternatives to weigh Bayan Health against.
Medications: what Bayan Health prescribes
Bayan Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Bayan Health's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Bayan Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Bayan Health earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Bayan Health scores best in our breakdown.
Ready to start with Bayan Health?
Starting at $99/month. See current pricing and start your free consultation.
Bayan Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Bayan Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Bayan Health's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.